Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Clinical trial NCT00389428 · COMPLETED

Trial details

NCT number: NCT00389428
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2006-09-01
Primary completion: 2008-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.